FPI Stock Recent News

Data suggests that Farmland Partners Inc. offers diversification benefits with a weak correlation to major equity and real estate ETFs. The REIT's business model includes leasing agricultural land, selling crops, and providing ancillary services, ensuring revenue diversification. Strong fundamentals, including high collection rates, long-term leases, and involvement in renewable energy, support a positive outlook for 2025.

Farmland Partners executed two significant transactions in Q4 2024 producing proceeds of $308 million and exiting the Florida, South and North Carolina farmland markets. The transaction increases the significance of California permanent crop farms which are more difficult to value. I estimate FPI's AFFO should increase to $0.35-$0.40/share in 2025 driven by deleveraging and cost savings. Even so, the AFFO multiple remains too high.

DENVER--(BUSINESS WIRE)--Farmland Partners Inc. (NYSE: FPI) (the “Company” or “FPI”) today announced that its Board of Directors has declared a one-time dividend of $1.15 per share of common stock and Class A Common OP Unit, payable in cash on January 8, 2025 to shareholders of record on December 23, 2024. The announcement comes at the end of a year that saw the Company sell farmland and related assets for consideration totaling approximately $308 million, generating a total gain for FPI of app.

Patient Enrolled at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier® in Patients with Solid Tumors Not Responding to Anti-PD-1 Antibodies SAN DIEGO , Nov. 11, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced enrollment of the first patient in its Australian safety, feasibility and dose-finding clinical trial of the Hemopurifier® in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda® (pembrolizumab) or Opdivo® (nivolumab) (AEMD-2022-06 Hemopurifier Study). The patient was enrolled on October 29, 2024, by Prof.

Farmland Partners, Inc. (NYSE:FPI ) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ET Company Participants Christine Garrison - General Counsel Luca Fabbri - President and CEO Paul Pittman - Executive Chairman Susan Landi - Chief Financial Officer Conference Call Participants Robert Stevenson - Janney Scott Fortune - ROTH Capital Partners Buck Horne - Raymond James John Massocca - B. Riley Craig Kucera - Lucid Capital Markets Operator Thank you for standing by.

While the top- and bottom-line numbers for Farmland Partners (FPI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Farmland Partners (FPI) came out with quarterly funds from operations (FFO) of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.01 per share a year ago.

REITs have surged by nearly 40% on average. But some specific REITs missed out on this rally. I highlight 2 REITs that still present significant upside potential.

DENVER--(BUSINESS WIRE)--Farmland Partners Inc. (NYSE: FPI) (the “Company”) today announced it will release its financial results for the quarter ended September 30, 2024, after 5 p.m. (Eastern Time) on Wednesday, October 30, 2024, and will host a conference call the following day, Thursday, October 31, 2024, at 11:00 a.m. (Eastern Time) to discuss the financial results and provide a company update. The call can be accessed live over the phone by dialing 1-800-715-9871 and using the conference.

DENVER--(BUSINESS WIRE)--Farmland Partners Inc. (NYSE: FPI) (the “Company” or “FPI”) today confirmed that the recently announced sale of a portfolio of farmland to Farmland Reserve, Inc. (“Farmland Reserve”) closed as scheduled on October 16, 2024 (the “Transaction”). The portfolio sold to Farmland Reserve consisted of 46 farms, comprising 41,554 acres of farmland in Arkansas, Florida, Louisiana, Mississippi, Nebraska, Oklahoma, and the Carolinas. The $289 million all-cash Transaction generated.